Literature DB >> 12583818

A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.

M Robinson1, L Ginnelly, M Sculpher, L Jones, S Palmer, Z Philips, J Glanville.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12583818

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  3 in total

Review 1.  'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.

Authors:  Andrea Manca; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Economic evaluation of the impact of nicorandil in angina (IONA) trial.

Authors:  A Walker; J McMurray; S Stewart; W Berger; A D McMahon; H Dargie; K Fox; S Hillis; N J K Henderson; I Ford
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

3.  The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?

Authors:  Edo Kaluski
Journal:  Curr Cardiol Rev       Date:  2008-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.